---
title: "Pliant Therapeutics Announces Upcoming Presentation at the 2026 American Society of Clinical Oncology Annual Meeting | PLRX Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/287275540.md"
description: "Pliant Therapeutics Announces Upcoming Presentation at the 2026 American Society of Clinical Oncology Annual Meeting | PLRX Stock News"
datetime: "2026-05-21T13:30:32.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/287275540.md)
  - [en](https://longbridge.com/en/news/287275540.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/287275540.md)
---

# Pliant Therapeutics Announces Upcoming Presentation at the 2026 American Society of Clinical Oncology Annual Meeting | PLRX Stock News

Pliant Therapeutics Announces Upcoming Presentation at the 2026 American Society of Clinical Oncology Annual Meeting | PLRX Stock News

### Related Stocks

- [PLRX.US](https://longbridge.com/en/quote/PLRX.US.md)

## Related News & Research

- [Pliant Therapeutics, Inc. $PLRX Stock Position Raised by ADAR1 Capital Management LLC](https://longbridge.com/en/news/294166622.md)
- [How to invest in 2026 without losing to inflation](https://longbridge.com/en/news/294516161.md)
- [Monroe Capital: Meeting adjourned for lack of quorum; rescheduled for August 11th, 2026](https://longbridge.com/en/news/294105513.md)
- [Candel Therapeutics to present extended Phase 3 data on aglatimagene besadenovec in localized prostate cancer at ASTRO 2026](https://longbridge.com/en/news/294690616.md)
- [Candel Therapeutics to Present Extended Data from Phase 3 Results of Aglatimagene Besadenovec at ASTRO 2026 | CADL Stock News](https://longbridge.com/en/news/294690870.md)